Lenograstim
Top View
- White Blood Cell Colony Stimulating Factors – Value & Balance Exchange Medical Benefit Drug Policy
- Horizon Scanning Status Report June 2020 Prepared For: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036
- (G-Csfs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim): New Warning Regarding Aortitis
- Lenograstim-Mobilized Peripheral Blood Progenitor Cells in Volunteer Donors: an Open Label Randomized Split Dose Escalating Study
- Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
- Granocyte Data Sheet
- Lonquex 6 Mg Solution for Injection in Pre-Filled Syringe
- Peripheral Blood Progenitor Cells Mobilization in Patients with Multiple Myeloma
- Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantat
- Publication Only
- Targeting the FMS-Like Tyrosine Kinase 3 in Acute Myeloid Leukemia
- Human Granulocyte-Colony Stimulating Factor (G-CSF)/Stem Cell Factor (SCF) Fusion Proteins: Design, Characterization and Activity
- Haematological Malignancies
- How I Treat Patients Who Mobilize Hematopoietic Stem Cells Poorly
- A Randomized Study Comparing Filgrastim Versus Lenograstim Versus Molgramostim Plus Chemotherapy for Peripheral Blood Progenitor
- Mitigative Efficacy of the Clinical Dosage Administration Of
- BQC19 Core Analyses Table of Contents
- Lonquex, INN-Lipegfilgrastim